Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cygnus GlucoWatch G2

This article was originally published in The Gray Sheet

Executive Summary

PMA supplement approval for next-generation glucose monitor system is announced April 2. Enhancements over earlier model include a shorter waiting period between readings, an ability to display and store readings every ten minutes, and an audible alert providing "predictive" notification before a pre-set low glucose level is encountered. U.S. sales of the first-generation system, approved in March 2001, are expected to begin in the next few weeks. Introduction the G2 system will happen later this year...

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts